HIGHLIGHTS
- who: Sahan Jayawardana from the affordable given the resource and budget constraints in South Africa have published the article: Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis, in the Journal: (JOURNAL)
- what: Compared to previous work, the study has three key strengths which enabled the authors to more precisely characterise the epidemiological and economic impact of the M72/AS01E vaccine in South Africa: the use of strategies elicited from expert interview; modelling repeat mass vaccination campaigns and_(3) targeting PLHIV for vaccination. This work has important implications . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.